J. Goldman & Co’s BioNTech BNTX Stock Holding History

J. Goldman & Co’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,700	Closed	-$293K	–	357
2023 Q3	$293K	Hold	2,700	–	–	0.01%	305
2023 Q2	$291K	Hold	2,700	–	–	0.01%	314
2023 Q1	$336K	Buy	+2,700	New	+$371K	0.01%	291

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

J. Goldman & Co's BNTX Position: Q4 2023 in Review

J. Goldman & Co sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 2,700 shares — an estimated $293K sold.

J. Goldman & Co first reported a position in BNTX in Q1 2023 and held it in 3 quarters. The position peaked at $336K in Q1 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

J. Goldman & Co reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
J. Goldman & Co sold 2,700 BioNTech shares in Q4 2023, an estimated $293K.
J. Goldman & Co first reported a position in BioNTech in Q1 2023 and held it in 3 quarters.
J. Goldman & Co's BioNTech position peaked at $336K in Q1 2023.
282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on J. Goldman & Co's 13F filing for Q4 2023, filed 14 Feb 2024.